Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | APEX1 | P27695 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 2/20 | 0.46 |
| ▸ | CES1 | P23141 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.46 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL72171 | 1.00 | TP53 (0.68) | TP53TSHRTDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL938198 | 1.00 | TP53 (0.68) | TP53TSHRTDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL57818 | 1.00 | TP53 (0.68) | TP53TSHRTDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL29777001 | 1.00 | TP53 (0.68) | TP53TSHRTDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL6532887 | 1.00 | TP53 (0.68) | TP53TSHRTDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL6309997 | 1.00 | TP53 (0.68) | TP53TSHRTDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL883098 | 1.00 | TP53 (0.68) | TP53TSHRTDP1ALDH1A1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL19279013 | 0.98 | TP53 (0.66) | TP53TSHRTDP1ALDH1A1SMN1; SMN2 | |
| Water SCHEMBL1322822 | 0.98 | TP53 (0.66) | TP53TSHRTDP1ALDH1A1SMN1; SMN2 | |
| Water SCHEMBL743190 | 0.98 | TP53 (0.66) | TP53TSHRTDP1ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5425 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4722214-A1 | METHOD OF PREPARING FINERENONE, INTERMEDIATE COMPOUND OF FINERENONE, AND METHOD OF PREPARING THE INTERMEDIATE COMPOUND | JW Pharmaceutical Corporation (KR) | 2026-04-08 | — | — | EP | claimed |
| EP-4642776-A1 | SALTS AND SOLID FORMS OF SONROTOCLAX INTERMEDIATE | Beone Medicines I GmbH (CH) | 2025-11-05 | — | — | EP | claimed |
| US-20250276974-A1 | PROCESS FOR PREPARING ZANUBRUTINIB IN AMORPHOUS FORM | OLON S.P.A. (IT) | 2025-09-04 | — | — | US | claimed |
| US-20250270184-A1 | PROCESSES FOR THE PREPARATION OF FINERENONE | ASSIA CHEMICAL INDUSTRIES LTD. (IL) | 2025-08-28 | — | — | US | claimed |
| EP-4606429-A2 | VMAT2 INHIBITORS AND METHODS OF USE | Neurocrine Biosciences, Inc. (US) | 2025-08-27 | — | — | EP | claimed |
| WO-2025133917-A1 | PROCESS FOR THE PREPARATION OF (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5- ETHOXY-1, 4-DIHYDRO-2,8-DIMETHYL-1,6-NAPTHYRIDINE-3-CARBOXAMIDE | INDUSTRIALE CHIMICA S.R.L. (IT) | 2025-06-26 | — | — | WO | claimed |
| US-20250136605-A1 | IMPROVED METHODS FOR PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVES | IMMUNOGEN, INC. | 2025-05-01 | — | — | US | claimed |
| US-20250115601-A1 | PROCESS FOR THE PREPARATION OF FINERENONE AND INTERMEDIATES THEREOF | ALIVUS LIFE SCIENCES LIMITED (IN) | 2025-04-10 | — | — | US | claimed |
| EP-4526302-A1 | PROCESS FOR THE PREPARATION OF FINERENONE AND INTERMEDIATES THEREOF | Alivus Life Sciences Limited (IN) | 2025-03-26 | — | — | EP | claimed |
| EP-4522619-A1 | PROCESS FOR PREPARING ZANUBRUTINIB IN AMORPHOUS FORM | OLON S.p.A. (IT) | 2025-03-19 | — | — | EP | claimed |
| EP-0420120-B1 | Optically active benzyl alcohol compound and pharmaceutical composition | HOKURIKU PHARMACEUTICAL (JP) | 1994-08-31 | — | — | EP | claimed |
| US-5274117-A | Heating a racemic oxindole, a halogenated acetonitrile and a catalyst to form the alkylated oxindole | HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) | 1993-12-28 | — | — | US | claimed |
| EP-0501774-A1 | Preparation of substituted tetrahydropyridines | ELI LILLY AND COMPANY (US) | 1992-09-02 | — | — | EP | claimed |
| EP-0487237-A1 | New optically active metoprolol tartrate salts, and method of preparing them, and method of preparing optically active metoprolol from the tartrate salts | Nitto Denko Co. Ltd. (JP) | 1992-05-27 | — | — | EP | claimed |
| EP-0472325-A2 | Acid addition salts of an optically active alaninanilide compound and pharmaceutical compositions containing the same | Kissei Pharmaceutical Co., Ltd. (JP) | 1992-02-26 | — | — | EP | claimed |
| EP-0438796-A2 | Process for the enantioselection synthesis of alkylated oxindoles used as intermediates in the preparation of physostigmine | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1991-07-31 | — | — | EP | claimed |
| EP-0420120-A2 | Optically active benzyl alcohol compound and pharmaceutical composition | HOKURIKU PHARMACEUTICAL CO., LTD. (JP) | 1991-04-03 | — | — | EP | claimed |
| EP-0418770-A2 | Process for the chemical resolution of 5-alkoxy-substituted (+/-)-1,3-dimethyloxindolylethylamines | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1991-03-27 | — | — | EP | claimed |
| US-4353918-A | ANTIINFLAMMATORY, ANTIRHEUMATIC | CIBA-GEIGY CORPORATION (US) | 1982-10-12 | — | — | US | claimed |
| US-4329469-A | SUSPENSION, SALT FORMATION | MERCK & CO., INC. (US) | 1982-05-11 | — | — | US | claimed |